SGLT-2 inhibitors in frail patients with heart failure

Int J Cardiol. 2022 Apr 1:352:102-103. doi: 10.1016/j.ijcard.2022.01.067. Epub 2022 Feb 5.

Author

Olivier Luc Charansonney¹

Affiliation

¹ Department of Cardiology, Centre Hospitalier Sud Francilien, 40, Avenue Serge Dassault, 91106 Corbeil-Essonnes cedex, France; Department of Clinical Physiology, Hôpital Lariboisière, 2, Rue Ambroise Paré, 75010 Paris, France. Electronic address: olivier.charansonney@chsf.fr.

PMID: 35134445
DOI: 10.1016/j.ijcard.2022.01.067

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aged
Diabetes Mellitus, Type 2*
Frail Elderly
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors